Kotoka Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kotoka Nakamura has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Sumeet S. Chugh
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
7 shared publications - Kyndaron Reinier
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
6 shared publications - Harpriya Chugh
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
5 shared publications - Audrey Uy-Evanado
Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States
4 shared publications - Jonathan Jui
Department of Emergency Medicine, Oregon Health and Science University, Portland (J.J.).
3 shared publications Angelo Salvucci
2 shared publications
Latest Publications
- 8 July 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (8) , e014647
Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest
BACKGROUND: At least 50% of individuals who suffer sudden cardiac arrest (SCA) have warning symptoms before their SCA, but these are not sufficient to predict imminent SCA (ISCA). We hypothesized that combining symptoms with clinical profile could effectively predict ISCA. METHODS: In 2 community-based studies of SCA in Oregon and California, survivors of SCA who had experienced warning symptoms and called 911 (n=364) were compared with control subjects (n=313) who also called 911 for similar symptoms but did not have SCA. Symptom information was obtained directly from interviews as well as prehospital emergency records. We used machine learning to identify predictive combinations of symptoms and clinical features in this case-control study. The area under the receiver operating characteristic curve (AUC) and 5-fold cross-validation were used to assess model performance and stability. RESULTS: Warning symptom-clinical profile combinations were successfully identified. The combination of chest pain and known heart failure predicted ISCA among males, while chest pain and known coronary artery disease predicted ISCA among females (AUC=0.788). With dyspnea, both history of coronary artery disease and heart failure were predictors (AUC=0.745). In the absence of chest pain or dyspnea, seizure-like symptoms, coronary artery disease, and heart failure were predictors (AUC, 0.775). 5-fold cross-validation produced consistent results. CONCLUSIONS: Combinations of warning symptoms and clinical features distinguished individuals with SCA from individuals without SCA with good accuracy (AUCs, 0.745–0.788). These findings have implications for clinical triage of ISCA warning symptoms in emergency settings and warrant investigation in larger studies.
- 8 July 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (8) , e014647
Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest
BACKGROUND: At least 50% of individuals who suffer sudden cardiac arrest (SCA) have warning symptoms before their SCA, but these are not sufficient to predict imminent SCA (ISCA). We hypothesized that combining symptoms with clinical profile could effectively predict ISCA. METHODS: In 2 community-based studies of SCA in Oregon and California, survivors of SCA who had experienced warning symptoms and called 911 (n=364) were compared with control subjects (n=313) who also called 911 for similar symptoms but did not have SCA. Symptom information was obtained directly from interviews as well as prehospital emergency records. We used machine learning to identify predictive combinations of symptoms and clinical features in this case-control study. The area under the receiver operating characteristic curve (AUC) and 5-fold cross-validation were used to assess model performance and stability. RESULTS: Warning symptom-clinical profile combinations were successfully identified. The combination of chest pain and known heart failure predicted ISCA among males, while chest pain and known coronary artery disease predicted ISCA among females (AUC=0.788). With dyspnea, both history of coronary artery disease and heart failure were predictors (AUC=0.745). In the absence of chest pain or dyspnea, seizure-like symptoms, coronary artery disease, and heart failure were predictors (AUC, 0.775). 5-fold cross-validation produced consistent results. CONCLUSIONS: Combinations of warning symptoms and clinical features distinguished individuals with SCA from individuals without SCA with good accuracy (AUCs, 0.745–0.788). These findings have implications for clinical triage of ISCA warning symptoms in emergency settings and warrant investigation in larger studies.
- Open Access
A Clinical Prediction Model for Sudden Cardiac Arrest Presenting as Pulseless Electrical Activity
Background: The incidence of sudden cardiac arrest (SCA) manifesting as pulseless electrical activity (PEA) has increased, and survival remains extremely low. Methods for early identification and management of high-risk individuals are needed, but no clinical risk scores currently exist to predict PEA-SCA. Our objective was to develop and validate a clinical prediction model for PEA-SCA. Methods: From an ongoing prospective, population-based study of SCA in Portland, Oregon (catchment pop. ≈1 M, 2002-2020), we identified PEA-SCA adults. Lifetime clinical records were compared with those of a control group with >50% prevalence of significant coronary disease. Prediction models were constructed using backwards stepwise logistic regression in a training dataset (67%) and evaluated in a validation dataset (33%). Model discrimination was assessed using receiver operating characteristic curves (C statistic). External validation was performed in a geographically distinct population in Ventura County, California (population ≈850,000, 2015-2022). Results: The final clinical algorithm (PEA-Risk) incorporating 12 clinical, electrocardiogram and medication variables demonstrated strong discrimination in the training dataset (C statistic = 0.860 [95% CI: 0.838-0.881]) and remained robust in internal (C statistic = 0.832 [95% CI: 0.800-0.865]) and external validation datasets (C statistic = 0.704 [95% CI: 0.665-0.743]). Conclusions: We developed and externally validated a clinical algorithm for predicting PEA-SCA. Given the low rates of successful resuscitation after PEA arrest, this risk prediction tool may enable earlier identification and prevention of PEA-SCA. Clinical Perspective: What is known: The proportion of SCA presenting as pulseless electrical activity (PEA) is increasing, and survival from these events remains extremely low. The are no available methods for clinical risk prediction of these events. What the study adds: The present study constructs and replicates a risk score for prediction of SCA manifesting with PEA using widely available clinical and noninvasive markers. These findings have implications for developing prevention and management strategies for individuals at high risk of PEA-SCA.
Open AccessA Clinical Prediction Model for Sudden Cardiac Arrest Presenting as Pulseless Electrical Activity
Background: The incidence of sudden cardiac arrest (SCA) manifesting as pulseless electrical activity (PEA) has increased, and survival remains extremely low. Methods for early identification and management of high-risk individuals are needed, but no clinical risk scores currently exist to predict PEA-SCA. Our objective was to develop and validate a clinical prediction model for PEA-SCA. Methods: From an ongoing prospective, population-based study of SCA in Portland, Oregon (catchment pop. ≈1 M, 2002-2020), we identified PEA-SCA adults. Lifetime clinical records were compared with those of a control group with >50% prevalence of significant coronary disease. Prediction models were constructed using backwards stepwise logistic regression in a training dataset (67%) and evaluated in a validation dataset (33%). Model discrimination was assessed using receiver operating characteristic curves (C statistic). External validation was performed in a geographically distinct population in Ventura County, California (population ≈850,000, 2015-2022). Results: The final clinical algorithm (PEA-Risk) incorporating 12 clinical, electrocardiogram and medication variables demonstrated strong discrimination in the training dataset (C statistic = 0.860 [95% CI: 0.838-0.881]) and remained robust in internal (C statistic = 0.832 [95% CI: 0.800-0.865]) and external validation datasets (C statistic = 0.704 [95% CI: 0.665-0.743]). Conclusions: We developed and externally validated a clinical algorithm for predicting PEA-SCA. Given the low rates of successful resuscitation after PEA arrest, this risk prediction tool may enable earlier identification and prevention of PEA-SCA. Clinical Perspective: What is known: The proportion of SCA presenting as pulseless electrical activity (PEA) is increasing, and survival from these events remains extremely low. The are no available methods for clinical risk prediction of these events. What the study adds: The present study constructs and replicates a risk score for prediction of SCA manifesting with PEA using widely available clinical and noninvasive markers. These findings have implications for developing prevention and management strategies for individuals at high risk of PEA-SCA.
- Open Access
- 17 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (6) , oeaf131
Markers of sudden cardiac death associated with the ventricular-paced 12-lead ECG
Introduction: ECG markers are associated with increased risk of sudden cardiac arrest (SCA) on the sinus rhythm ECG. A sizeable subgroup of patients at risk receives cardiac implantable electrical devices, but there are no known markers of SCA risk on the ventricular-paced (VP) ECG. Methods and results: We conducted a case-control analysis within a community-based SCA study in Oregon USA (2002–2020; ∼1 million catchment population) with validation in an identically designed study in California USA (2015–2023; ∼850 000 catchment population). SCA cases included adults (≥18 years) with archived VP ECGs obtained prior and unrelated to their SCA. Controls met the same ECG criteria but without history of ventricular arrhythmias or SCA. The discovery analysis included 158 participants (119 SCA, 39 controls), mean age 76.9 ± 11.8 years. SCA cases had a higher ventricular rate (74.9 ± 16.0 bpm vs. 69.3 ± 12.0 bpm, P = 0.05), longer corrected QT interval (QTc; 525.9 ± 49.9 ms vs. 493.9 ± 31.0 ms, P < 0.001) and longer Tpeak-Tend (Tpe; 111.8 ± 23.3 ms vs. 95.9 ± 20.1 ms, P < 0.001). After adjustment, QTc and Tpe were significantly associated with SCA, with adjusted ORs 6.1 (95%CI: 1.4–26.2) and 7.9 (95%CI: 2.0–31.0) in the discovery population, and 6.1 (95%CI: 2.5–14.8) and 3.7 (95%CI: 1.6–8.6) in the validation population. In pooled analysis, the model combining QTc and Tpe achieved an AUC of 0.752, significantly outperforming each individually. Subjects with both prolonged QTc and Tpe had a 16-fold higher risk (adjusted OR:16.2, 95%CI: 6.0–43.6) compared to those without abnormalities. Conclusion: Abnormal myocardial repolarization measured by QTc and Tpe was independently associated with SCA. These findings suggest that the VP ECG could also predict SCA risk.
- 17 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (6) , oeaf131
Open AccessMarkers of sudden cardiac death associated with the ventricular-paced 12-lead ECG
Introduction: ECG markers are associated with increased risk of sudden cardiac arrest (SCA) on the sinus rhythm ECG. A sizeable subgroup of patients at risk receives cardiac implantable electrical devices, but there are no known markers of SCA risk on the ventricular-paced (VP) ECG. Methods and results: We conducted a case-control analysis within a community-based SCA study in Oregon USA (2002–2020; ∼1 million catchment population) with validation in an identically designed study in California USA (2015–2023; ∼850 000 catchment population). SCA cases included adults (≥18 years) with archived VP ECGs obtained prior and unrelated to their SCA. Controls met the same ECG criteria but without history of ventricular arrhythmias or SCA. The discovery analysis included 158 participants (119 SCA, 39 controls), mean age 76.9 ± 11.8 years. SCA cases had a higher ventricular rate (74.9 ± 16.0 bpm vs. 69.3 ± 12.0 bpm, P = 0.05), longer corrected QT interval (QTc; 525.9 ± 49.9 ms vs. 493.9 ± 31.0 ms, P < 0.001) and longer Tpeak-Tend (Tpe; 111.8 ± 23.3 ms vs. 95.9 ± 20.1 ms, P < 0.001). After adjustment, QTc and Tpe were significantly associated with SCA, with adjusted ORs 6.1 (95%CI: 1.4–26.2) and 7.9 (95%CI: 2.0–31.0) in the discovery population, and 6.1 (95%CI: 2.5–14.8) and 3.7 (95%CI: 1.6–8.6) in the validation population. In pooled analysis, the model combining QTc and Tpe achieved an AUC of 0.752, significantly outperforming each individually. Subjects with both prolonged QTc and Tpe had a 16-fold higher risk (adjusted OR:16.2, 95%CI: 6.0–43.6) compared to those without abnormalities. Conclusion: Abnormal myocardial repolarization measured by QTc and Tpe was independently associated with SCA. These findings suggest that the VP ECG could also predict SCA risk.
- Open Access
Genetic Causes of Sudden Cardiac Arrest in the Community
Background: Annually 300,000 Americans experience sudden cardiac arrest (SCA). Studies in referral SCA cohorts have observed rare variants in genes associated with arrhythmia and cardiomyopathy. We sought to: (1) establish the population prevalence of rare disease-causing variants in a set of candidate genes and (2) confirm the association of disease-causing variants in these genes with SCA in two prospective population-based studies. Methods: SCA patients (n=3264) were accrued from the Oregon Sudden Unexpected Death Study and the PREdiction of Sudden death in mulTi-ethnic cOmmunities (PRESTO) study and compared to control patients (n=13713) from the Atherosclerosis Risk in Communities (ARIC) study. Whole genome sequencing was performed. Disease-causing (likely pathogenic or pathogenic) variants in candidate genes associated with arrhythmia/cardiomyopathy were identified using updated American College of Medical Genetics and Genomics criteria. Gene- collapsing case-control analysis was performed using the conditional logistic regression-sequence kernel association test. Results: We identified 300 disease-causing variants, the majority of which were in cardiomyopathy genes (71%). There were 136 patients (4.2%) in the SCA group and 351 patients (2.6%) in the control group with one or more disease-causing variants (OR 1.66, 95% confidence interval 1.33-2.07, pBAG3, DSC2, DSG2, FLNC, LMNA, MYBPC3, TNNI3, TNNT2, TTN ) and four with arrhythmia ( CACNA1C, CASQ2, KCNH2, KCNQ1 ). Conclusions: Disease-causing variants in cardiomyopathy genes were the predominant genetic cause of SCA. These findings inform which genes to include in genetic screening for SCA.
Open AccessGenetic Causes of Sudden Cardiac Arrest in the Community
Background: Annually 300,000 Americans experience sudden cardiac arrest (SCA). Studies in referral SCA cohorts have observed rare variants in genes associated with arrhythmia and cardiomyopathy. We sought to: (1) establish the population prevalence of rare disease-causing variants in a set of candidate genes and (2) confirm the association of disease-causing variants in these genes with SCA in two prospective population-based studies. Methods: SCA patients (n=3264) were accrued from the Oregon Sudden Unexpected Death Study and the PREdiction of Sudden death in mulTi-ethnic cOmmunities (PRESTO) study and compared to control patients (n=13713) from the Atherosclerosis Risk in Communities (ARIC) study. Whole genome sequencing was performed. Disease-causing (likely pathogenic or pathogenic) variants in candidate genes associated with arrhythmia/cardiomyopathy were identified using updated American College of Medical Genetics and Genomics criteria. Gene- collapsing case-control analysis was performed using the conditional logistic regression-sequence kernel association test. Results: We identified 300 disease-causing variants, the majority of which were in cardiomyopathy genes (71%). There were 136 patients (4.2%) in the SCA group and 351 patients (2.6%) in the control group with one or more disease-causing variants (OR 1.66, 95% confidence interval 1.33-2.07, pBAG3, DSC2, DSG2, FLNC, LMNA, MYBPC3, TNNI3, TNNT2, TTN ) and four with arrhythmia ( CACNA1C, CASQ2, KCNH2, KCNQ1 ). Conclusions: Disease-causing variants in cardiomyopathy genes were the predominant genetic cause of SCA. These findings inform which genes to include in genetic screening for SCA.
- Top Cited PapersOpen Access
- 27 February 2024
- Published by Springer Nature in Communications Medicine
- Vol. 4 (1) , 1-9
An ECG-based artificial intelligence model for assessment of sudden cardiac death risk
Background: Conventional ECG-based algorithms could contribute to sudden cardiac death (SCD) risk stratification but demonstrate moderate predictive capabilities. Deep learning (DL) models use the entire digital signal and could potentially improve predictive power. We aimed to train and validate a 12 lead ECG-based DL algorithm for SCD risk assessment. Methods: Out-of-hospital SCD cases were prospectively ascertained in the Portland, Oregon, metro area. A total of 1,827 pre- cardiac arrest 12 lead ECGs from 1,796 SCD cases were retrospectively collected and analyzed to develop an ECG-based DL model. External validation was performed in 714 ECGs from 714 SCD cases from Ventura County, CA. Two separate control group samples were obtained from 1342 ECGs taken from 1325 individuals of which at least 50% had established coronary artery disease. The DL model was compared with a previously validated conventional 6 variable ECG risk model. Results: The DL model achieves an AUROC of 0.889 (95% CI 0.861–0.917) for the detection of SCD cases vs. controls in the internal held-out test dataset, and is successfully validated in external SCD cases with an AUROC of 0.820 (0.794–0.847). The DL model performs significantly better than the conventional ECG model that achieves an AUROC of 0.712 (0.668–0.756) in the internal and 0.743 (0.711–0.775) in the external cohort. Conclusions: An ECG-based DL model distinguishes SCD cases from controls with improved accuracy and performs better than a conventional ECG risk model. Further detailed investigation is warranted to evaluate how the DL model could contribute to improved SCD risk stratification.
- 27 February 2024
- Published by Springer Nature in Communications Medicine
- Vol. 4 (1) , 1-9
Top Cited PapersOpen AccessAn ECG-based artificial intelligence model for assessment of sudden cardiac death risk
Background: Conventional ECG-based algorithms could contribute to sudden cardiac death (SCD) risk stratification but demonstrate moderate predictive capabilities. Deep learning (DL) models use the entire digital signal and could potentially improve predictive power. We aimed to train and validate a 12 lead ECG-based DL algorithm for SCD risk assessment. Methods: Out-of-hospital SCD cases were prospectively ascertained in the Portland, Oregon, metro area. A total of 1,827 pre- cardiac arrest 12 lead ECGs from 1,796 SCD cases were retrospectively collected and analyzed to develop an ECG-based DL model. External validation was performed in 714 ECGs from 714 SCD cases from Ventura County, CA. Two separate control group samples were obtained from 1342 ECGs taken from 1325 individuals of which at least 50% had established coronary artery disease. The DL model was compared with a previously validated conventional 6 variable ECG risk model. Results: The DL model achieves an AUROC of 0.889 (95% CI 0.861–0.917) for the detection of SCD cases vs. controls in the internal held-out test dataset, and is successfully validated in external SCD cases with an AUROC of 0.820 (0.794–0.847). The DL model performs significantly better than the conventional ECG model that achieves an AUROC of 0.712 (0.668–0.756) in the internal and 0.743 (0.711–0.775) in the external cohort. Conclusions: An ECG-based DL model distinguishes SCD cases from controls with improved accuracy and performs better than a conventional ECG risk model. Further detailed investigation is warranted to evaluate how the DL model could contribute to improved SCD risk stratification.
- Open Access
- 27 July 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S86
B-PO01-089 SUDDEN CARDIAC ARREST DURING THE COVID-19 PANDEMIC: SIGNIFICANT EFFECTS ON INCIDENCE AND OUTCOMES
- 27 July 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S86
Open AccessB-PO01-089 SUDDEN CARDIAC ARREST DURING THE COVID-19 PANDEMIC: SIGNIFICANT EFFECTS ON INCIDENCE AND OUTCOMES
- 12 February 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (7_suppleme)
Abrogation of Phenotype by Small Molecule Read-Through Compounds in a Human Model of Ataxia Telangiectasia (P05.048)
- 12 February 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (7_suppleme)
Abrogation of Phenotype by Small Molecule Read-Through Compounds in a Human Model of Ataxia Telangiectasia (P05.048)